scholarly journals Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement

2013 ◽  
Vol 65 (3) ◽  
pp. 382-390 ◽  
Author(s):  
Marie Tanzer ◽  
Cheryl Tran ◽  
Kassandra L. Messer ◽  
Amber Kroeker ◽  
Emily Herreshoff ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Health Care Utilization ◽  
Children And Adolescents ◽  
Lupus Erythematosus ◽  
Care Utilization ◽  
Systemic Lupus ◽  
Kidney Involvement

scholarly journals Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs

2015 ◽  
Vol 67 (8) ◽  
pp. 1086-1094 ◽  
Author(s):  
Shih-Yin Chen ◽  
Chan-Bum Choi ◽  
Qian Li ◽  
Wei-Shi Yeh ◽  
Yuan-Chi Lee ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Health Care Utilization ◽  
Lupus Erythematosus ◽  
Care Utilization ◽  
Systemic Lupus

“Protenuria in SLE: Is it always lupus?”

Lupus ◽  
2021 ◽  
pp. 096120332098345
Author(s):  
Alessandra Ida Celia ◽  
Roberta Priori ◽  
Bruna Cerbelli ◽  
Francesca Diomedi-Camassei ◽  
Vincenzo Leuzzi ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Nephritis ◽  
Fabry Disease ◽  
Histological Examination ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Kidney Involvement ◽  
History Of ◽  
Genetic Assay

Proteinuria is one of the most typical manifestations of kidney involvement in Systemic Lupus Erythematosus (SLE). We report the case of a 23-year-old woman with a 6-year-long history of SLE presenting with proteinuria after a three-year remission on hydroxychloroquine. Kidney histological examination showed alterations inconsistent with lupus nephritis and suggestive of hydroxychloroquine toxicity or Fabry disease. The latter was confirmed by genetic assay.

scholarly journals Health care in systemic lupus erythematosus (SLE): the patient’s perspective

2014 ◽  
Vol 33 (9) ◽  
pp. 1279-1287 ◽  
Author(s):  
E. J. M. Zirkzee ◽  
G. M. Steup-Beekman ◽  
A. A. Schouffoer ◽  
S. M. Henquet ◽  
M. A. A. Caljouw ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Patient’S Perspective

scholarly journals CLINICAL AND LABORATORIAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDREN AND ADOLESCENTS

2019 ◽  
Author(s):  
ROGÉRIO DO PRADO ◽  
THAIS AKEMI YOSHIMOTO ◽  
ALINE RODRIGUES LORETO ◽  
BEATRIZ JERONYMO PARDI ◽  
ROSELI O S SARNI
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Children And Adolescents ◽  
Lupus Erythematosus ◽  
Systemic Lupus

scholarly journals Telerheumatology: A Narrative Review

2021 ◽  
Vol 2 (3) ◽  
pp. 139-145
Author(s):  
Wei Tang ◽  
Leila Khalili ◽  
Anca Askanase
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Clinical Trials ◽  
Lupus Erythematosus ◽  
Delivery Of Health Care ◽  
Healthcare Professionals ◽  
Direct Consequence ◽  
Systemic Lupus ◽  
Rheumatology Practice

Abstract Telemedicine (TM), the delivery of health care using telecommunication technologies, has been in use in rheumatology practice for over two decades to maximize access and optimize care. As a direct consequence of the Coronavirus disease 2019 (COVID-19) pandemic in March 2020, rheumatology practice shifted from traditional in-person encounters to TM to ensure the safety of both healthcare professionals and patients. However, there is limited literature on the acceptance, feasibility, and effectiveness of TM in the management of rheumatic diseases. Additionally, there is limited guidance on the implementation of telerheumatology (TR) for both patient care and clinical trials. Here we reviewed the most recent publications related to the application of TR, in the management of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE), assessed the perceptions of patients and physicians on TM in rheumatology, and identified several key barriers to TR.

Sign in / Sign up

Export Citation Format

Share Document